ADVFN Logo

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.
Progyny Inc

Progyny Inc (PGNY)

38.15
0.16
(0.42%)
Closed March 28 04:00PM
38.15
0.00
(0.00%)
After Hours: 06:10PM

Unlock more advanced trading tools

Join ADVFN today

Key stats and details

Current Price
38.15
Bid
37.70
Ask
38.62
Volume
695,603
37.81 Day's Range 38.98
29.44 52 Week Range 44.95
Market Cap
Previous Close
37.99
Open
37.91
Last Trade Time
Financial Volume
$ 26,781,801
VWAP
38.5016
Average Volume (3m)
821,572
Shares Outstanding
96,499,402
Dividend Yield
-
PE Ratio
59.26
Earnings Per Share (EPS)
0.64
Revenue
1.09B
Net Profit
62.04M

About Progyny Inc

Progyny Inc is a company engaged in specializing in fertility and family building benefits solutions. Its clients include employers across various industries. The fertility benefits solution consists of the treatment services (Smart Cycles), access to the Progyny network of high-quality fertility sp... Progyny Inc is a company engaged in specializing in fertility and family building benefits solutions. Its clients include employers across various industries. The fertility benefits solution consists of the treatment services (Smart Cycles), access to the Progyny network of high-quality fertility specialists that perform the Smart Cycle treatments and active management of the selective network of high-quality provider clinics. Show more

Sector
Misc Health & Allied Svc,nec
Industry
Misc Health & Allied Svc,nec
Website
Headquarters
Wilmington, Delaware, USA
Founded
1970
Progyny Inc is listed in the Misc Health & Allied Svc sector of the NASDAQ with ticker PGNY. The last closing price for Progyny was $37.99. Over the last year, Progyny shares have traded in a share price range of $ 29.44 to $ 44.95.

Progyny currently has 96,499,402 shares outstanding. The market capitalization of Progyny is $3.68 billion. Progyny has a price to earnings ratio (PE ratio) of 59.26.

PGNY Latest News

Progyny, Inc. to Present at KeyBanc Life Sciences & MedTech Investor Forum

NEW YORK, March 18, 2024 (GLOBE NEWSWIRE) -- Progyny, Inc. (Nasdaq: PGNY), a transformative fertility, family building, and women’s health benefits solution, today announced that Pete Anevski...

Progyny, Inc. to Present at Barclays 26th Annual Global Healthcare Conference

NEW YORK, March 11, 2024 (GLOBE NEWSWIRE) -- Progyny, Inc. (Nasdaq: PGNY), a transformative fertility, family building, and women’s health benefits solution, today announced that Pete Anevski...

Form 4 - Statement of changes in beneficial ownership of securities

SEC Form 4 FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSIONWashington, D.C. 20549STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIPFiled pursuant to Section 16(a) of the Securities Exchange...

Form 4 - Statement of changes in beneficial ownership of securities

SEC Form 4 FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSIONWashington, D.C. 20549STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIPFiled pursuant to Section 16(a) of the Securities Exchange...

Form 4 - Statement of changes in beneficial ownership of securities

SEC Form 4 FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSIONWashington, D.C. 20549STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIPFiled pursuant to Section 16(a) of the Securities Exchange...

Form 144 - Report of proposed sale of securities

="/Images/box-unchecked.jpg" alt="Checkbox not checked">961003/01/2024Cash* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the...

Form 144 - Report of proposed sale of securities

="/Images/box-unchecked.jpg" alt="Checkbox not checked">649402/26/2024Compensation* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain...

Form S-8 - Securities to be offered to employees in employee benefit plans

As filed with the Securities and Exchange Commission on February 29, 2024. Registration No. 333- UNITED STATESSECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549FORM S-8 REGISTRATION...

PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
11.353.6684782608736.838.9836.677685337.28399164CS
42.587.2533033455235.5738.9833.5594103935.99453914CS
121.754.8076923076936.442.0833.0782157237.38727692CS
263.710.74020319334.4542.0829.4478191535.37034638CS
524.4413.171165826233.7144.9529.4476401336.08037728CS
156-5.86-13.315155646444.0168.3225.6782307942.05413908CS
26023.14154.1638907415.0168.3214.990581075238.43010685CS

Market Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
AVTXAvalo Therapeutics Inc
$ 22.08
(364.84%)
31.9M
NXLNexalin Technologies Inc
$ 1.50
(92.31%)
11.67M
CEROCERo Therapeutics Holdings Inc
$ 3.112
(90.92%)
24.08M
BDRXBiodexa Pharmaceuticals PLC
$ 1.6201
(88.60%)
88.37M
KYCHKeyarch Acquisition Corporation
$ 12.30
(75.58%)
196.62k
BOLDBoundless Bio Inc
 14.25
(-76.24%)
767.63k
PMECPrimech Holdings Ltd
$ 1.2999
(-66.50%)
8.28M
TNXPTonix Pharmaceuticals Holding Corporation
$ 0.1816
(-44.45%)
21.92M
GMDAGamida Cell Ltd
$ 0.036
(-39.19%)
89.18M
NBSTWNewbury Street Acquisition Corporation
$ 0.042279
(-38.28%)
1.75k
NKLANikola Corporation
$ 1.035
(13.85%)
163.84M
GMDAGamida Cell Ltd
$ 0.036
(-39.19%)
89.18M
BDRXBiodexa Pharmaceuticals PLC
$ 1.6201
(88.60%)
88.37M
MARAMarathon Digital Holdings Inc
$ 22.56
(2.22%)
86.14M
AKANAkanda Corporation
$ 0.1166
(-29.29%)
80.34M

PGNY Discussion

View Posts
JPetroInc JPetroInc 4 years ago
1 hell of a drop today - ugh!
👍️0
JPetroInc JPetroInc 4 years ago
$PGNY holding up well
👍️0
pauljack13 pauljack13 4 years ago
They were already mentioned on Investors Business Daily.
Starting to be known. Good growth small cap.
👍️0
JPetroInc JPetroInc 4 years ago
PGNY is an IPO that has flown under the financial awareness radar

I suspect they'll launch an 'awareness campaign' sometime after the 1st
👍️0
JPetroInc JPetroInc 4 years ago
non-stop buying spree today off the low of $23

this is going to $31 quickly

I suspect they will have a large awareness campaign soon

PGNY is expected to announce break even this FY20
👍️0
JPetroInc JPetroInc 4 years ago
IPO retracement finding support around $23 pps

👍️0
JPetroInc JPetroInc 4 years ago
Progyny, Inc. Announces Pricing of Initial Public Offering

Date : 10/25/2019 @ 12:01AM
Source : GlobeNewswire Inc.
Stock : Progyny Inc (PGNY)
Quote : 25.99 0.0 (0.00%)

Progyny (NASDAQ:PGNY)

https://ih.advfn.com/stock-market/NASDAQ/progyny-PGNY/stock-news/80991562/progyny-inc-announces-pricing-of-initial-public

Progyny, Inc., a leading benefits management company specializing in fertility and family building benefits solutions in the United States, today announced the pricing of its initial public offering of 10,000,000 shares of its common stock at a price to the public of $13.00 per share. Progyny is offering 6,700,000 shares and the selling stockholders are offering 3,300,000 shares. In addition, certain selling stockholders have granted the underwriters a 30-day option to purchase up to an additional 1,500,000 shares of common stock at the initial public offering price less the underwriting discount. The shares are expected to begin trading on the Nasdaq Global Select Market under the ticker symbol “PGNY” on October 25, 2019, and the offering is expected to close on October 29, 2019, subject to customary closing conditions.

J.P. Morgan, Goldman Sachs & Co. LLC and BofA Securities are acting as joint lead book-running managers for the offering. Citigroup is acting as book-running manager for the offering. Piper Jaffray, SVB Leerink and TPG Capital BD, LLC are acting as co-managers for the offering.

The offering is being made only by means of a prospectus. Copies of the final prospectus, when available, may be obtained from: J.P. Morgan Securities LLC, 383 Madison Avenue, New York, New York 10179, Attn: Prospectus Department, Telephone: 866-803-9204, Email: prospectus-eq_fi@jpmchase.com; Goldman Sachs & Co. LLC, 200 West Street, New York, New York 10282, Attn: Prospectus Department, Telephone: 866-471-2526, Facsimile: 212-902-9316, Email: prospectus-ny@ny.email.gs.com; and BofA Securities, One Bryant Park, New York, New York 10036, Attn: Prospectus Department, Email: dg.prospectus_requests@baml.com.

A registration statement relating to these securities has been filed with, and declared effective by, the U.S. Securities and Exchange Commission (SEC). Copies of the registration statement can be accessed through the SEC’s website at www.sec.gov. This press release shall not constitute an offer to sell or the solicitation of an offer to buy these securities, nor shall there be any sale of these securities in any state or jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state or jurisdiction.

About Progyny

Progyny is a leading fertility benefits management company in the United States. We are redefining fertility and family building benefits, proving that a comprehensive and inclusive fertility solution can simultaneously benefit employers, patients, and physicians. Our benefits solution empowers patients with education and guidance from a dedicated Patient Care Advocate (PCA), provides access to a premier network of fertility specialists using the latest science and technologies, reduces healthcare costs for the nation’s leading employers, and drives optimal clinical outcomes. We envision a world where anyone who wants to have a child can do so.

Contact

Progyny PR

Selena Yang
media@progyny.com

Progyny IR

James Hart
investors@progyny.com

👍️0

Your Recent History

Delayed Upgrade Clock